The Urinary Tract Infection Testing Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global market for urinary tract infection testing devices has seen robust growth in recent years. The market size is set to increase from $0.62 billion in 2024 to $0.67 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%.
The global market size for urinary tract infection testing devices is projected to reach $0.86 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.6%.
Download Your Free Sample of the 2025 Urinary Tract Infection Testing Devices Market Report and Uncover Key Trends Now!The key drivers in the urinary tract infection testing devices market are:
•Rising popularity of at-home and self-testing kits
•Growing predilection for early diagnosis
•Surge in efforts to fight antibiotic resistance
•Advanced innovations and integration of AI and machine learning in testing devices
The urinary tract infection testing devices market covered in this report is segmented –
1) By Product type: Instruments, Kits
2) By Test Type: Urinalysis, Urine Cultures, Susceptibility Testing
3) By End-User: Hospitals, Diagnostic Labs, Other End Users
Subsegments:
1) By Instruments: Automated UTI Analyzers, UTI Culture Systems, UTI Microscopes, UTI Diagnostic Devices (Handheld Devices)
2) By Kits: UTI Test Strips, UTI Reagents, Urine Culture Kits, UTI Home Testing Kits
The key trends in the urinary tract infection testing devices market are:
•Integration of AI and machine learning in urinary tract infection testing devices is an emerging trend.
•Innovations in at-home testing devices are on the rise.
•Technological advancements are shaping the future of the market.
•The development of nanotechnology-based diagnostics and CRISPR-based diagnostic tools is a significant upcoming trend.
Major players in the urinary tract infection testing devices market are:
• Cardinal Health Inc.
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Medtronic plc
• Siemens Healthcare GmbH
• Stryker Corporation
• Laboratory Corporation of America Holdings
• Biomerieux Pvt. Ltd.
• Coloplast A/S
• Sysmex Corporation
• Quidel Corporation
• Teleflex Incorporated
• Teleflex Incorporated
• Bio-Rad Laboratories
• QIAGEN NV
• ACON Laboratories Inc.
• Randox Laboratories Ltd.
• ARKRAY Inc.
• T2 Biosystems Inc.
North America was the largest region in the urinary tract infection testing devices market in 2024